A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells. / Andersen, P S; Stryhn, A; Hansen, B E; Fugger, L; Engberg, J; Buus, S.
I: Proceedings of the National Academy of Science of the United States of America, Bind 93, Nr. 5, 1996, s. 1820-4.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - A recombinant antibody with the antigen-specific, major histocompatibility complex-restricted specificity of T cells
AU - Andersen, P S
AU - Stryhn, A
AU - Hansen, B E
AU - Fugger, L
AU - Engberg, J
AU - Buus, S
N1 - Keywords: Amino Acid Sequence; Animals; Antibody Specificity; Bacteriophages; Gene Library; Major Histocompatibility Complex; Mice; Mice, Inbred AKR; Molecular Sequence Data; Peptides; Recombinant Proteins; T-Lymphocytes
PY - 1996
Y1 - 1996
N2 - Specific recognition of peptide/major histocompatibility complex (MHC) molecule complexes by the T-cell receptor is a key reaction in the specific immune response. Antibodies against peptide/MHC complexes would therefore be valuable tools in studying MHC function and T-cell recognition and might lead to novel approaches in immunotherapy. However, it has proven difficult to generate antibodies with the specificity of T cells by conventional hybridoma techniques. Here we report that the phage display technology is a feasible alternative to generate antibodies recognizing specific, predetermined peptide/MHC complexes.
AB - Specific recognition of peptide/major histocompatibility complex (MHC) molecule complexes by the T-cell receptor is a key reaction in the specific immune response. Antibodies against peptide/MHC complexes would therefore be valuable tools in studying MHC function and T-cell recognition and might lead to novel approaches in immunotherapy. However, it has proven difficult to generate antibodies with the specificity of T cells by conventional hybridoma techniques. Here we report that the phage display technology is a feasible alternative to generate antibodies recognizing specific, predetermined peptide/MHC complexes.
M3 - Journal article
C2 - 8700842
VL - 93
SP - 1820
EP - 1824
JO - Proceedings of the National Academy of Sciences of the United States of America
JF - Proceedings of the National Academy of Sciences of the United States of America
SN - 0027-8424
IS - 5
ER -
ID: 9945624